Skip to content

BrachySource™ 1251CSRARecalls & reported problems

Bard Brachytherapy, Inc. · BrachySource™ I-125 Implant Seed in Cartridges · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741078279), received between Mar 15, 2019 and Mar 15, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Inadequate Instructions for Healthcare Professional” (1 report).

1 other recall cover devices cleared under the same FDA submission (K093663); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Inadequate Instructions for Healthcare Professional1
  • Manufacturing, Packaging or Shipping Problem1

Patient problems

  • No Consequences Or Impact To Patient1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 15, 2019Inadequate Instructions for Healthcare Professional; Manufacturing, Packaging or Shipping Problem; Inadequate Instructions for Healthcare Professional

    IT WAS REPORTED THAT THE SEEDS WERE SHIPPED TO SURGERY FOR UROLOGY IN (B)(6) INSTEAD OF (B)(6) MEDICAL CENTER IN (B)(6). THE SEEDS WERE DRIVEN TO (B)(6) MEDICAL CENTER FROM (B)(6) FOR THE SCHEDULED IMPLANT. THERE WAS A 2-3 HOUR SURGICAL DELAY DUE TO THE DELIVERY ERROR. HOWEVER, THE PATIENT RECEIVED THEIR FULL PRESCRIBED DOSE.

    Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient

    MAUDE report 8425321 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K093663. One submission often covers many models, so check the product and lot details in each record.

  • Z-1702-2018 · Apr 10, 2018 · Terminated
    BARD BrachySource Iodine125 radioactive seeds consist of a welded titanium capsule containing the I125 absorbed onto a nickel / copper-coated, gold-cored aluminum wire (reference F

Other Source, brachytherapy, radionuclide devices

All Source, brachytherapy, radionuclide devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.